TAP Block , Intrathecal Morphine Or Their Combination For Post Operative Analgesia Following TAH

NCT ID: NCT06882369

Last Updated: 2025-03-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE1

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-11-01

Study Completion Date

2025-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized controlled clinical trial designed to evaluate the efficacy of transversus abdominis plane (TAP) block, intrathecal morphine, or their combination in postoperative pain relief, as assessed by time to first analgesic request, pain scores, total postoperative analgesic consumption, time of ambulation, complications and hemodynamics following total abdominal hysterectomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-operative Pain Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TAP block

Bilateral ultrasound-guided TAP block with 20 mL of 0.25% plain bupivacaine on each side of the abdomen at the end of surgery.

Group Type ACTIVE_COMPARATOR

TAP Block

Intervention Type PROCEDURE

The transabdominal plane (TAP) block is a regional anesthesia technique used for postoperative pain management in abdominal wall procedures, providing somatic analgesia to the anterior and lateral abdominal walls

spinal anesthesia

Intervention Type DRUG

intrathecal injection of bupivacaine

Intrathecal Morphine

Intrathecal injection of 100 µg morphine plus 20 mg hyperbaric bupivacaine (in spinal anesthesia).

Group Type ACTIVE_COMPARATOR

Intrathecal morphine injection

Intervention Type DRUG

Intrathecal injection of morphine plus 20 mg hyperbaric bupivacaine in spinal anesthesia

spinal anesthesia

Intervention Type DRUG

intrathecal injection of bupivacaine

Combined

Intrathecal injection of 50 µg morphine plus 20 mg hyperbaric bupivacaine combined with bilateral ultrasound-guided TAP block using 20 mL of 0.25% plain bupivacaine on each side of the abdomen at the end of surgery.

Group Type ACTIVE_COMPARATOR

TAP Block

Intervention Type PROCEDURE

The transabdominal plane (TAP) block is a regional anesthesia technique used for postoperative pain management in abdominal wall procedures, providing somatic analgesia to the anterior and lateral abdominal walls

Intrathecal morphine injection

Intervention Type DRUG

Intrathecal injection of morphine plus 20 mg hyperbaric bupivacaine in spinal anesthesia

spinal anesthesia

Intervention Type DRUG

intrathecal injection of bupivacaine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TAP Block

The transabdominal plane (TAP) block is a regional anesthesia technique used for postoperative pain management in abdominal wall procedures, providing somatic analgesia to the anterior and lateral abdominal walls

Intervention Type PROCEDURE

Intrathecal morphine injection

Intrathecal injection of morphine plus 20 mg hyperbaric bupivacaine in spinal anesthesia

Intervention Type DRUG

spinal anesthesia

intrathecal injection of bupivacaine

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female patients aged 30 to 70 years.
* Elective total abdominal hysterectomy.
* ASA physical status I or II.
* Willingness to provide informed consent.

Exclusion Criteria

* Refusal of the block.
* Allergy to study medications.
* Preexisting coagulation disorders.
* Local infection at the site of needle insertion.
* Uncontrolled respiratory or cardiac disorders.
* Impaired kidney or liver function.
Minimum Eligible Age

30 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Minia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Islam Ahmed Bakr Mohammed

lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

sohair Adeeb, assist.prof.

Role: PRINCIPAL_INVESTIGATOR

Minia University, faculty of medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Medicine, Minia University

Minya, Minya Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TAP vs. morphine vs. both

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of TAP Block on Stress Hormones
NCT03443271 COMPLETED PHASE4